PlainPill

Cordyceps vs LGD-4033 for performance

Short answer: For performance, more users report improvement with Cordyceps — 98% of 41 reports, versus 90% of 178 for LGD-4033.

Cordyceps has 21 meta-analyses and 32 randomized trials on PubMed; LGD-4033 has 1 and 1.

Based on 368 reports about Cordyceps and 491 about LGD-4033. Not medical advice.

Cordyceps
Supplement
LGD-4033
SARM
User score5354
Verdict
Mostly positive
Mixed
Positive
of reports that state an outcome
67%50%
Reports368491
ResearchAResearch: StrongBResearch: Moderate
Meta-analyses / RCTs21 / 321 / 1
Mainly used for
Weight loss
% reporting improvement
100% (2)94% (33)
Appetite
% reporting improvement
50% (2)60% (5)
Focus
% reporting improvement
76% (21)50% (4)
Energy
% reporting improvement
88% (83)45% (22)
Sleep
% reporting improvement
43% (7)17% (6)
Anxiety
% reporting improvement
33% (6)0% (3)
Mood
% reporting improvement
90% (20)25% (24)
Memory
% reporting improvement
67% (3)—
Performance
% reporting improvement
98% (41)90% (178)
Recovery
% reporting improvement
100% (3)100% (13)
Pain & inflammation
% reporting improvement
100% (3)0% (5)
Digestion
% reporting improvement
—50% (2)
Libido
% reporting improvement
84% (19)19% (27)
Hormones
% reporting improvement
83% (12)4% (48)
Heart & lipids
% reporting improvement
100% (7)0% (12)
Skin & hair
% reporting improvement
—0% (3)
Common side effectsanxiety, insomnia, drowsiness, fatiguesuppression, water retention, fatigue, stomach issues
Typical dose reporteddailyNot listed
Cordyceps
Latest review conclusion

Nevertheless, the evidence is inconclusive to recommend the routine use of mushrooms for cancer patients. More trials are needed to explore mushroom use during and after cancer treatment.

Curr Oncol Rep, 2023 ↗
What a user said
“A few grams in the morning mixed in with water, I feel more alert throughout the day and have more energy but have trouble falling asleep and wake up early.”
Full Cordyceps profile →
LGD-4033
Latest review conclusion

SARMs have a positive effect on physical performance and body composition and are associated with moderate rates of mild to moderate adverse effects (AEs) and a low rate of severe AEs.

Clin Endocrinol (Oxf), 2025 ↗
What a user said
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
Full LGD-4033 profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate